Effects of probiotics in rats with experimental metabolic syndrome and periodontitis: An investigation of the intestine–adipose tissue axis

Abstract

BackgroundThis study evaluated the systemic (intestine and adipose tissue) and local (periodontal tissues) impact of probiotic therapy in rats with metabolic syndrome (MS) associated or not with periodontitis (PE).MethodsForty‐eight rats received a high‐fat diet for induction of MS for 16 weeks. They were subdivided into groups with (+) and without (−) PE, receiving (*) or not (**) receiving probiotics (PROB): MS (−**), MSP (−*), MSPE (+**), and MSPEP (+*). PROB administration (Bifidobacterium animalis subsp. lactis HN019) started on the 8th week of the study and PE was induced on the 14th week by placing ligature on the animals’ lower first molars. Euthanasia occurred in the 16th week. Biomolecular, immunoenzymatic assays, and histomorphometric analyses were performed. The data obtained were statistically analyzed (ANOVA, Tukey, p < 0.05).ResultsThe MSPEP group exhibited reduced alveolar bone loss when compared with the MSPE group, as well as lower levels of hepatic steatosis and proteinuria (p < 0.05). In the intestinal environment, the MSPE group exhibited significantly lower villus height and crypt depth, as well as a greater increase in Bacillota when compared with the MSPEP group (p < 0.05). The MSPEP group showed lower adipokine gene expression (LEPR, NAMPT, and FABP4) in adipose tissue than the MSPE group (p < 0.05).ConclusionThe probiotic B. lactis HN019 reduced the severity of experimental periodontitis and modulated the expression of lipogenic genes and intestinal morphological and microbiological parameters in rats with MS.

Probiotics enhance alveolar bone microarchitecture, intestinal morphology and estradiol levels in osteoporotic animals

“…[18][19][20][21] Nutritional supplementation with probiotics has been studied to modulate the intestinal microbiota and immune system. 17,20,22 Probiotics have been successfully evaluated in various conditions, including gastrointestinal disorders, 23 immune-related conditions, 24,25 metabolic diseases 26 and oral pathologies, such as periodontal disease. 27 The literature indicates that probiotics may prevent the loss of bone mass associated with estrogen depletion.…”